Price T Rowe Associates Inc Pharma Cyte Biotech, Inc. Transaction History

Price T Rowe Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.83 - $3.03 $30,564 - $32,723	-10,800 Reduced 29.67%	25,600 $75,000
Q4 2022 Feb 14, 2023	SELL	$2.39 - $3.07 $25,334 - $32,542	-10,600 Reduced 22.55%	36,400 $106,000
Q3 2022 Nov 14, 2022	SELL	$2.24 - $2.85 $33,600 - $42,750	-15,000 Reduced 24.19%	47,000 $113,000
Q2 2022 Aug 15, 2022	SELL	$1.99 - $2.33 $32,039 - $37,513	-16,100 Reduced 20.61%	62,000 $140,000
Q4 2021 Feb 14, 2022	SELL	$2.4 - $3.19 $133,200 - $177,045	-55,500 Reduced 41.54%	78,100 $195,000
Q3 2021 Nov 15, 2021	BUY	$2.28 - $16.9 $304,608 - $2.26 Million	133,600 New	133,600 $424,000

932K

Ticker PMCB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,750,100
Market Cap $33.2M
Description
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.